{
  "id": "PK_OATP_INHIB",
  "name": "OATP inhibition can increase exposure of OATP substrates",
  "domain": "PK",
  "severity": "major",
  "rule_class": "adjust_monitor",
  "tags": ["exposure_increase"],
  "actions": [
    "Consider interaction risk when combining OATP inhibitors with OATP substrates (educational).",
    "If used together, monitor for dose-related adverse effects of the affected drug.",
    "Recognize that uptake transporter effects can be substrate- and dose-dependent."
  ],
  "logic": {
    "transporter": {
      "family": "OATP",
      "A_role": "substrate",
      "B_role": "inhibitor",
      "B_strength_in": ["moderate", "strong"]
    },
    "rationale": [
      "{B_name} inhibits hepatic uptake transport (OATP), which can reduce hepatic clearance of {A_name}.",
      "Reduced uptake into the liver can increase systemic exposure of some OATP substrates."
    ]
  },
  "explanation_template": "{B_name} inhibits OATP transport and {A_name} is an OATP substrate. This may increase {A_name} exposure, raising the risk of dose-related adverse effects.",
  "references": [
    {
      "source": "Educational note",
      "citation": "Mechanistic pattern: uptake transporter inhibition can increase exposure of certain substrates."
    }
  ]
}
